Detalhe da pesquisa
1.
Characterization of HOXB13 expression patterns in localized and metastatic castration-resistant prostate cancer.
J Pathol
; 262(1): 105-120, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37850574
2.
Paracrine Wnt signaling is necessary for prostate epithelial proliferation.
Prostate
; 82(5): 517-530, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35014711
3.
A Phase 1 study of gefitinib combined with durvalumab in EGFR TKI-naive patients with EGFR mutation-positive locally advanced/metastatic non-small-cell lung cancer.
Br J Cancer
; 124(2): 383-390, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33012782
4.
Retrospective analysis of Schlafen11 (SLFN11) to predict the outcomes to therapies affecting the DNA damage response.
Br J Cancer
; 125(12): 1666-1676, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34663950
5.
A phase II study to assess the safety and efficacy of the dual mTORC1/2 inhibitor vistusertib in relapsed, refractory DLBCL.
Hematol Oncol
; 37(4): 352-359, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31385336
6.
Characterizing the molecular features of ERG-positive tumors in primary and castration resistant prostate cancer.
Prostate
; 76(9): 810-22, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26990456
7.
Single Cell Analysis of Treatment-Resistant Prostate Cancer: Implications of Cell State Changes for Cell Surface Antigen Targeted Therapies.
bioRxiv
; 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38645034
8.
Androgen-regulated stromal complement component 7 (C7) suppresses prostate cancer growth.
Oncogene
; 42(32): 2428-2438, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37400528
9.
Metastatic Bladder Cancer Expression and Subcellular Localization of Nectin-4 and Trop-2 in Variant Histology: A Rapid Autopsy Study.
Clin Genitourin Cancer
; 21(6): 669-678, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37344281
10.
A Phase 1/2 Study of Rapamycin and Cisplatin/Gemcitabine for Treatment of Patients With Muscle-Invasive Bladder Cancer.
Clin Genitourin Cancer
; 21(2): 265-272, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36710146
11.
Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancer.
JCI Insight
; 8(7)2023 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36821396
12.
Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy.
Nat Commun
; 14(1): 2041, 2023 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37041154
13.
Tumor-derived biomarkers predict efficacy of B7H3 antibody-drug conjugate treatment in metastatic prostate cancer models.
J Clin Invest
; 133(22)2023 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37725435
14.
ASSESSMENT OF CELL SURFACE TARGETS IN METASTATIC PROSTATE CANCER: EXPRESSION LANDSCAPE AND MOLECULAR CORRELATES.
Res Sq
; 2023 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38196594
15.
Therapeutic Implications for Intrinsic Phenotype Classification of Metastatic Castration-Resistant Prostate Cancer.
Clin Cancer Res
; 28(14): 3127-3140, 2022 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35552660
16.
Stromal FOXF2 suppresses prostate cancer progression and metastasis by enhancing antitumor immunity.
Nat Commun
; 13(1): 6828, 2022 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36369237
17.
Comprehensive assessment of anaplastic lymphoma kinase in localized and metastatic prostate cancer reveals targetable alterations.
Cancer Res Commun
; 2(5): 277-285, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36337169
18.
Molecular Pathology of Prostate Cancer.
Surg Pathol Clin
; 14(3): 387-401, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34373091
19.
Genomic and phenotypic heterogeneity in prostate cancer.
Nat Rev Urol
; 18(2): 79-92, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33328650
20.
Tumor genomic, transcriptomic, and immune profiling characterizes differential response to first-line platinum chemotherapy in high grade serous ovarian cancer.
Cancer Med
; 10(9): 3045-3058, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33811746